IsoPlexis: Siddhartha Kadia

Siddhartha Kadia has joined the board of directors of single-cell proteomics firm IsoPlexis. Previously, he was president of the life sciences division at Life Technologies; president and CEO of EAG Laboratories; and corporate VP at Invitrogen. He also serves as director of NuVasive, ALS, Applied Technical Services (ATS), and BioSkryb Genomics. Kadia holds a master's degree from Rutgers University and a PhD in biomedical engineering from Johns Hopkins University.